Although most cases of AD are sporadic, every mutation known to segregate with familial early-onset AD (FAD) confers increased production of neurotoxic amyloid-β (Aβ) peptides by altering proteolytic processing of APP (O'Brien and Wong, 2011). Here, APP is linked to Alzheimer disease.